• The company will be present in Valladolid from May 20 to 22 to share its latest developments for the bovine sector with veterinary professionals
• Labiana continues to focus on innovation, pharmaceutical quality, the responsible use of veterinary medicines and technical support for the sector

Madrid, May 20, 2026 – Labiana, a pharmaceutical company specialised in animal and human health and listed on BME Growth, will once again attend the ANEMBE International Congress on Bovine Medicine, taking place from May 20 to 22 in Valladolid.

The company will participate in this leading event for bovine medicine professionals, where it will share its latest developments in animal health with veterinarians and industry specialists, in line with its commitment to innovation, pharmaceutical quality and the responsible use of veterinary medicines.

At ANEMBE, Labiana will present some of the latest additions to its bovine portfolio, including solutions designed to address specific needs in veterinary practice on dairy farms, while incorporating improvements in key aspects for clinical use, such as formulation, concentration and withdrawal periods, always in accordance with the product information of each medicine and under veterinary prescription and supervision.

During the congress, Labiana will welcome attending professionals at stands 21-22, where its technical and commercial team will provide information on the company’s bovine solutions, always within the framework of applicable regulations and under the principle of veterinary prescription and supervision.

Cattle are one of the main livestock species in Spain and represent one of the most significant agri-food productions in the European Union. In this context, Labiana maintains a longstanding connection with the livestock sector and with the development of solutions aimed at supporting the work of veterinary professionals and contributing to animal health and welfare.

With more than 60 years of experience linked to the sector, Labiana has solid expertise in animal health and specialised industrial capabilities, including one of Spain’s leading veterinary injectable manufacturing plants, located in Terrassa.
According to Antonio José Ortiz, Commercial Director of Labiana Life, “At Labiana, we are committed to developing solutions that respond to the real needs of veterinary professionals, with special attention to innovation, pharmaceutical quality and key aspects in clinical practice such as formulation, concentration and withdrawal periods, always in accordance with the product information of each medicine and within the framework of veterinary prescription and responsible use. At ANEMBE, we will share some of our latest developments for the bovine sector.”

Labiana will be present at the ANEMBE International Congress on Bovine Medicine at stands 21-22 from May 20 to 22 in Valladolid.